These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27054282)

  • 21. Uncertainties beyond statistics in Monte Carlo simulations.
    Hughes HG
    Radiat Prot Dosimetry; 2007; 126(1-4):45-51. PubMed ID: 17766264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of variability and uncertainty with known measurement error: methodology and case study.
    Zheng J; Frey HC
    Risk Anal; 2005 Jun; 25(3):663-75. PubMed ID: 16022698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric characterization of an 192Ir brachytherapy source with the Monte Carlo code PENELOPE.
    Casado FJ; García-Pareja S; Cenizo E; Mateo B; Bodineau C; Galán P
    Phys Med; 2010; 26(3):132-9. PubMed ID: 20034828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying uncertainty in NMR T2 spectra using Monte Carlo inversion.
    Prange M; Song YQ
    J Magn Reson; 2009 Jan; 196(1):54-60. PubMed ID: 18952474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propagation of uncertainty in nasal spray in vitro performance models using Monte Carlo simulation: Part II. Error propagation during product performance modeling.
    Guo C; Doub WH; Kauffman JF
    J Pharm Sci; 2010 Aug; 99(8):3572-8. PubMed ID: 20564385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Harnessing the theoretical foundations of the exponential and beta-Poisson dose-response models to quantify parameter uncertainty using Markov Chain Monte Carlo.
    Schmidt PJ; Pintar KD; Fazil AM; Topp E
    Risk Anal; 2013 Sep; 33(9):1677-93. PubMed ID: 23311599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
    Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
    Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Separation of uncertainty and interindividual variability in human exposure modeling.
    Ragas AM; Brouwer FP; Büchner FL; Hendriks HW; Huijbregts MA
    J Expo Sci Environ Epidemiol; 2009 Feb; 19(2):201-12. PubMed ID: 18398446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Using CTS and PK-PD models to predict the effect of uncertainty about population parameters on clinical trial power].
    Zhu L; Shi X; Liu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Feb; 26(1):42-6, 62. PubMed ID: 19334551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Handling of contamination variability in exposure assessment: a case study with ochratoxin A.
    Counil E; Verger P; Volatier JL
    Food Chem Toxicol; 2005 Oct; 43(10):1541-55. PubMed ID: 15963619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Latent uncertainties of the precalculated track Monte Carlo method.
    Renaud MA; Roberge D; Seuntjens J
    Med Phys; 2015 Jan; 42(1):479-90. PubMed ID: 25563287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Built environment and behavior: spatial sampling using parcel data.
    Lee C; Moudon AV; Courbois JY
    Ann Epidemiol; 2006 May; 16(5):387-94. PubMed ID: 16005246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Monte Carlo study of the dependence of early frame sampling on uncertainty and bias in pharmacokinetic parameters from dynamic PET.
    Häggström I; Axelsson J; Schmidtlein CR; Karlsson M; Garpebring A; Johansson L; Sörensen J; Larsson A
    J Nucl Med Technol; 2015 Mar; 43(1):53-60. PubMed ID: 25613339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of flux distributions with Monte Carlo functional expansion tallies.
    Griesheimer DP; Martin WR; Holloway JP
    Radiat Prot Dosimetry; 2005; 115(1-4):428-32. PubMed ID: 16381761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A probabilistic approach to quantify the impact of uncertainty propagation in musculoskeletal simulations.
    Myers CA; Laz PJ; Shelburne KB; Davidson BS
    Ann Biomed Eng; 2015 May; 43(5):1098-111. PubMed ID: 25404535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uncertainty distribution associated with estimating a proportion in microbial risk assessment.
    Miconnet N; Cornu M; Beaufort A; Rosso L; Denis JB
    Risk Anal; 2005 Feb; 25(1):39-48. PubMed ID: 15787755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A fully Bayesian approach to the parcel-based detection-estimation of brain activity in fMRI.
    Makni S; Idier J; Vincent T; Thirion B; Dehaene-Lambertz G; Ciuciu P
    Neuroimage; 2008 Jul; 41(3):941-69. PubMed ID: 18439839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation.
    Barton HA; Chiu WA; Setzer RW; Andersen ME; Bailer AJ; Bois FY; Dewoskin RS; Hays S; Johanson G; Jones N; Loizou G; Macphail RC; Portier CJ; Spendiff M; Tan YM
    Toxicol Sci; 2007 Oct; 99(2):395-402. PubMed ID: 17483121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of variability and uncertainty for censored data sets and application to air toxic emission factors.
    Zhao Y; Frey HC
    Risk Anal; 2004 Aug; 24(4):1019-34. PubMed ID: 15357825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to account for uncertainty due to measurement errors in an uncertainty analysis using Monte Carlo simulation.
    Hofer E
    Health Phys; 2008 Sep; 95(3):277-90. PubMed ID: 18695409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.